[Mohs Micrographic Surgery for the management of basal cell carcinoma: experience at the Nîmes Univeristy Hospital]

Ann Pathol. 2007 Apr;27(2):74-9. doi: 10.1016/s0242-6498(07)91286-9.
[Article in French]

Abstract

Aims: The goal of this work was to assess the validity of Mohs Micrographic Surgery (MMS) for basal cell carcinoma (BCC) in a routine clinical setting.

Material and methods: Our adaptation of the technique described by Mohs and coll allows intraoperative histological examination of all surgical edges of the resection. Sixteen men and 4 women were selected.

Results: Average operative time was 2 hours 30 minutes. No false results were noted. The cosmetetic and functional outcomes were good.

Conclusion: MMS is a safe and reproducible surgical technique made possible by solid team work. It is adapted for the treatment of BCC with a high risk of recurrence. The cosmetetic and functional results are quite satisfactory. The recurrence rate at 5 years is 10 times less than with other methods of treatment. The additional time required for this surgery be put in balance with the number of tumors for which a second intervention would have been necessary if conventional surgery had been used. All procedures were performed under local anesthesia, and none or the patients required a second intervention.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Aged, 80 and over
  • Carcinoma, Basal Cell / pathology
  • Carcinoma, Basal Cell / surgery*
  • Female
  • France
  • Hospitals, University
  • Humans
  • Male
  • Middle Aged
  • Mohs Surgery*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery*